TNFAIP3 and atherosclerosis: The A20 anti-inflammatory and atheroprotective protein is also a target of O-GlcNAc modification; O-GlcNAc modification of A20 promotes ubiquitin–proteasome degradation, thereby accelerating atherosclerosis in diabetic ApoE-null mice [68].